Patents by Inventor Bernard Bene

Bernard Bene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11501878
    Abstract: An apparatus, a process and a system for monitoring a plurality of patients (P) affected by kidney failure over a time frame (T) are disclosed. The system includes blood treatment units, laboratory storage units, at least one hub module, and client units. The system collects values (VM) of a plurality of session parameters, set values (VS) of a plurality of prescription parameters, values (VL) of a plurality of laboratory parameters and the hub module stores values (KPVi) of selected parameters (KPi) which are a subclass of the collected values (VM, VS, VL) and which are transferred to the client units. Each client unit may define, for each of said patients, a number of indicators (IDk) based on the values (KPVi,k) taken by a respective subclass (KPi,k) of said selected parameters (KPi) and to operate the respective display according to various display modes.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: November 15, 2022
    Assignee: Gambro Lundia AB
    Inventors: Bernard Bene, Achille Fouilleul, Lionel Buttin
  • Patent number: 11311655
    Abstract: An apparatus and process for extracorporeal treatment of blood comprising a treatment unit, a blood withdrawal line, a blood return line, a preparation line and a spent dialysate line. A control unit is configured to calculate values of a parameter relating to treatment effectiveness based on measures of lactate or citrate or acetate concentration in the spent dialysate line.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: April 26, 2022
    Assignee: GAMBRO LUNDIA AB
    Inventors: Dominique Pouchoulin, Bernard Bene
  • Patent number: 10936699
    Abstract: An apparatus, a process and a system for monitoring a plurality of patients (P) affected by kidney failure over a time frame (T) are disclosed. The system includes blood treatment units, laboratory storage units, at least one hub module, and client units. The system collects values (VM) of a plurality of session parameters, set values (VS) of a plurality of prescription parameters, values (VL) of a plurality of laboratory parameters and the hub module stores values (KPVi) of selected parameters (KPi) which are a subclass of the collected values (VM, VS, VL) and which are transferred to the client units. Each client unit may define, for each of said patients, a number of indicators (IDk) based on the values (KPVi,k) taken by a respective subclass (KPi,k) of said selected parameters (KPi) and to operate the respective display according to various display modes.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: March 2, 2021
    Assignee: Gambro Lundia AB
    Inventors: Bernard Bene, Archille Fouilleul, Lionel Buttin
  • Publication number: 20210005315
    Abstract: An apparatus, a process and a system for monitoring a plurality of patients (P) affected by kidney failure over a time frame (T) are disclosed. The system includes blood treatment units, laboratory storage units, at least one hub module, and client units. The system collects values (VM) of a plurality of session parameters, set values (VS) of a plurality of prescription parameters, values (VL) of a plurality of laboratory parameters and the hub module stores values (KPVi) of selected parameters (KPi) which are a subclass of the collected values (VM, VS, VL) and which are transferred to the client units. Each client unit may define, for each of said patients, a number of indicators (IDk) based on the values (KPVi,k) taken by a respective subclass (KPi,k) of said selected parameters (KPi) and to operate the respective display according to various display modes.
    Type: Application
    Filed: September 23, 2020
    Publication date: January 7, 2021
    Inventors: Bernard Bene, Archille Fouilleul, Lionel Buttin
  • Publication number: 20200353142
    Abstract: An apparatus and process for extracorporeal treatment of blood comprising a treatment unit, a blood withdrawal line, a blood return line, a preparation line and a spent dialysate line. A control unit is configured to calculate values of a parameter relating to treatment effectiveness based on measures of lactate or citrate or acetate concentration in the spent dialysate line.
    Type: Application
    Filed: July 23, 2020
    Publication date: November 12, 2020
    Inventors: Dominique Pouchoulin, Bernard Bene
  • Patent number: 10786613
    Abstract: An apparatus and process for extracorporeal treatment of blood (1) comprising a treatment unit (2), a blood withdrawal line (6), a blood return line (7), a preparation line (19) and a spent dialysate line (13). A control unit (10) is configured to calculate values of a parameter relating to treatment effectiveness based on measures of lactate or citrate or acetate concentration in the spent dialysate line (13).
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: September 29, 2020
    Assignee: Gambro Lundia AB
    Inventors: Dominique Pouchoulin, Bernard Bene
  • Publication number: 20190134290
    Abstract: An apparatus and process for extracorporeal treatment of blood (1) comprising a treatment unit (2), a blood withdrawal line (6), a blood return line (7), a preparation line (19) and a spent dialysate line (13). A control unit (10) is configured to calculate values of a parameter relating to treatment effectiveness based on measures of lactate or citrate or acetate concentration in the spent dialysate line (13).
    Type: Application
    Filed: April 14, 2017
    Publication date: May 9, 2019
    Inventors: Dominique Pouchoulin, Bernard Bene
  • Patent number: 10179199
    Abstract: A medical apparatus for extracorporeal blood treatment and a method for determining blood parameter value have been provided. The medical apparatus has a control unit (9) configured for taking from a storage memory (10) a plurality of blood parameter value measures each made through the sensors (8) provided on the bloodline set of each of a machines plurality at different patient treatment sessions; all the blood parameter values relate to the same patient; receiving at least a corresponding laboratory measured valise of the same blood parameter relating to the same patient and a laboratory measurement time; determining a correction factor function of a difference between a measured value made though the sensor and a laboratory measured value; obtaining an actual value of said blood parameter by varying at least the last measure made through the sensor by means of the correcting factor.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: January 15, 2019
    Assignee: Gambro Lundia AB
    Inventor: Bernard Bene
  • Publication number: 20170364649
    Abstract: An apparatus, a process and a system for monitoring a plurality of patients (P) affected by kidney failure over a time frame (T) are disclosed. The system includes blood treatment units, laboratory storage units, at least one hub module, and client units. The system collects values (VM) of a plurality of session parameters, set values (VS) of a plurality of prescription parameters, values (VL) of a plurality of laboratory parameters and the hub module stores values (KPVi) of selected parameters (KPi) which are a subclass of the collected values (VM, VS, VL) and which are transferred to the client units. Each client unit may define, for each of said patients, a number of indicators (IDk) based on the values (KPVi,k) taken by a respective subclass (KPi,k) of said selected parameters (KPi) and to operate the respective display according to various display modes.
    Type: Application
    Filed: August 29, 2017
    Publication date: December 21, 2017
    Inventors: Bernard Bene, Archille Fouilleul, Lionel Buttin
  • Patent number: 9779212
    Abstract: An apparatus, a process and a system for monitoring a plurality of patients (P) affected by kidney failure over a time frame (T) are disclosed. The system includes blood treatment units, laboratory storage units, at least one hub module, and client units. The system collects values (VM) of a plurality of session parameters, set values (VS) of a plurality of prescription parameters, values (VL) of a plurality of laboratory parameters and the hub module stores values (KPVi) of selected parameters (KPi) which are a subclass of the collected values (VM, VS, VL) and which are transferred to the client units. Each client unit may define, for each of said patients, a number of indicators (IDk) based on the values (KPVi,k) taken by a respective subclass (KPi,k) of said selected parameters (KPi) and to operate the respective display according to various display modes.
    Type: Grant
    Filed: November 20, 2012
    Date of Patent: October 3, 2017
    Assignee: Gambro Lundia AB
    Inventors: Bernard Bene, Achille Fouilleul, Lionel Buttin
  • Patent number: 9585992
    Abstract: An apparatus for extracorporeal treatment of blood (1) comprising a treatment unit (2), a blood withdrawal line (6), a blood return line (7), a preparation line (19) and a spent dialysate line (13). A control unit (10) is configured to calculate values of a parameter relating to treatment effectiveness based on measures of the conductivity in the spent dialysate line (13) subsequent to an alternating conductivity perturbation continuously imposed on the preparation line (19) of fresh dialysis fluid.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: March 7, 2017
    Assignee: Gambro Lundia AB
    Inventor: Bernard Bene
  • Patent number: 9162020
    Abstract: Apparatus for controlling an extra-corporeal blood treatment in a medical device, comprising a blood treatment device (7), an extra-corporeal blood transport line (4), a fluid transport line (3) for a treatment fluid for the blood, at least a sensor adapted to provide a measure (M) correlated to at least a treatment parameter of the extra-corporeal blood treatment and/or of the treatment device (7) in the medical device (1), at least one storage memory (29), and at least a control device (28), operatively connected at least with the storage memory (29) and with the sensor, and configured for receiving the measure (M) from the sensor, correlating the measure (M) with referential data (R) of the treatment device for the treatment parameter provided by the at least one storage memory (29), and correlating the measure (M) with patient historical data (H) for the treatment parameter for obtaining an information representative of the quality of the extra-corporeal blood treatment.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: October 20, 2015
    Assignee: Gambro Lundia AB
    Inventors: Georges Vantard, Bernard Bene
  • Patent number: 9144639
    Abstract: Dialysis apparatus including a blood treatment unit having a dialysate chamber and a blood chamber separated by a semipermeable membrane, a dialysate circuit presenting a supply line and a discharge line connected to the blood treatment unit, a preparation device for preparing a dialysate containing a substance present in the blood too and a regulator regulating the concentration of the substance in the dialysate. A blood circuit to circulate extracorporeal blood through the blood chamber; a controller that determines a value representative of the concentration of the substance in the blood and are programmed for driving the regulator as a function of the determined value representative of the substance concentration in the blood such that the substance concentration in the dialysate tends towards the substance concentration in the blood.
    Type: Grant
    Filed: April 14, 2011
    Date of Patent: September 29, 2015
    Assignee: Gambro Lundia AB
    Inventors: Georges Vantard, Bernard Bene
  • Patent number: 9095661
    Abstract: An apparatus for controlling a fluid flow rate in a fluid transport line of a medical device, including at least a first pump, at least a chamber for collecting the fluid, at least a sensor for providing a first value correlated to the amount of fluid in the chamber, and a control device configured for receiving a second value representative of the fluid flow rate through the first pump and for correlating the second value with the first value to obtain an accuracy check of the second value. A method for controlling a fluid flow rate in a fluid transport line of a medical device including pumping a fluid, collecting the fluid in a chamber, sensing a first value correlated to the amount of fluid in the chamber, and detecting and sending a second value representative of the fluid flow rate through the first pump to a control device, sending the first value to the control device, and correlating the second value with the first value to obtain an accuracy check.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: August 4, 2015
    Assignee: Gambro Lundia AB
    Inventor: Bernard Bene
  • Publication number: 20150182680
    Abstract: A medical apparatus for extracorporeal blood treatment and a method for determining blood parameter value have been provided. The medical apparatus has a control unit (9) configured for taking from a storage memory (10) a plurality of blood parameter value measures each made through the sensors (8) provided on the bloodline set of each of a machines plurality at different patient treatment sessions; all the blood parameter values relate to the same patient; receiving at least a corresponding laboratory measured valise of the same blood parameter relating to the same patient and a laboratory measurement time; determining a correction factor function of a difference between a measured value made though the sensor and a laboratory measured value; obtaining an actual value of said blood parameter by varying at least the last measure made through the sensor by means of the correcting factor.
    Type: Application
    Filed: March 12, 2015
    Publication date: July 2, 2015
    Inventor: BERNARD BENE
  • Patent number: 9050421
    Abstract: The invention relates to a calculation and control system for the determination of the state of a vascular access of a patient intended to follow successive sessions of extracorporeal blood treatment by extraction and return of the blood via the vascular access, the system comprising: means for determining the value of at least one hemodynamic extracorporeal parameter of the patient for at least two sessions; means for determining the value of the purification effectiveness of the treatment for at least two sessions; programmed means for determining a risk score relating to the state of the vascular access of the patient as a function of at least two values of the hemodynamic extracorporeal parameter and of at least two determined values of the purification effectiveness.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: June 9, 2015
    Assignee: Gambro Lundia AB
    Inventor: Bernard Bene
  • Publication number: 20150129499
    Abstract: An apparatus for extracorporeal treatment of blood (1) comprising a treatment unit (2), a blood withdrawal line (6), a blood return line (7), a preparation line (19) and a spent dialysate line (13). A control unit (10) is configured to calculate values of a parameter relating to treatment effectiveness based on measures of the conductivity in the spent dialysate line (13) subsequent to an alternating conductivity perturbation continuously imposed on the preparation line (19) of fresh dialysis fluid.
    Type: Application
    Filed: June 14, 2013
    Publication date: May 14, 2015
    Inventor: Bernard Bene
  • Patent number: 9002655
    Abstract: A medical apparatus for extracorporeal blood treatment and a method for determining blood parameter value have been provided. The medical apparatus has a control unit (9) configured for taking from a storage memory (10) a plurality of blood parameter value measures each made through the sensors (8) provided on the bloodline set of each of a machines plurality at different patient treatment sessions; all the blood parameter values relate to the same patient; receiving at least a corresponding laboratory measured value of the same blood parameter relating to the same patient and a laboratory measurement time; determining a correction factor function of a difference between a measured value made though the sensor and a laboratory measured value; obtaining an actual value of said blood parameter by varying at least the last measure made through the sensor by means of the correcting factor.
    Type: Grant
    Filed: May 3, 2010
    Date of Patent: April 7, 2015
    Assignee: Gambro Lundia AB
    Inventor: Bernard Bene
  • Patent number: 8741147
    Abstract: A controller for blood treatment equipment comprising a treatment unit including a semipermeable membrane separating the treatment unit into a first compartment for the circulation of blood and a second compartment for the circulation of a treatment liquid is enclosed. The controller is adapted to receive one or more entries of information measured during the course of a treatment procedure, to calculate from said measured information a value of a significant parameter indicative of the progress of an extracorporeal blood treatment carried out by the equipment. The controller is also adapted to compare the calculated significant parameter to a prescribed reference value for the same parameter and to generate at least one output control signal responsive to said comparison for automatically controlling one or more operations performed by the equipment. Equipment comprising the controller and a control method the controller can be programmed to carry out are also disclosed.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: June 3, 2014
    Assignee: Gambro Lundia AB
    Inventors: Bernard Bene, Georges Vantard, Carl W. Reitz
  • Publication number: 20140100549
    Abstract: The invention relates to a calculation and control system for the determination of the state of a vascular access of a patient intended to follow successive sessions of extracorporeal blood treatment by extraction and return of the blood via the vascular access, the system comprising: means for determining the value of at least one hemodynamic extracorporeal parameter of the patient for at least two sessions; means for determining the value of the purification effectiveness of the treatment for at least two sessions; programmed means for determining a risk score relating to the state of the vascular access of the patient as a function of at least two values of the hemodynamic extracorporeal parameter and of at least two determined values of the purification effectiveness.
    Type: Application
    Filed: December 13, 2013
    Publication date: April 10, 2014
    Applicant: GAMBRO LUNDIA AB
    Inventor: Bernard BENE